Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma.
Aoki Y, Nojima M, Suzuki H, Yasui H, Maruyama R, Yamamoto E, Ashida M, Itagaki M, Asaoku H, Ikeda H, Hayashi T, Imai K, Mori M, Tokino T, Ishida T, Toyota M, Shinomura Y.
Aoki Y, et al.
Genome Med. 2012 Dec 22;4(12):101. doi: 10.1186/gm402. eCollection 2012.
Genome Med. 2012.
PMID: 23259664
Free PMC article.